130 related articles for article (PubMed ID: 10229875)
21. Roxithromycin specifically inhibits development of collagen induced arthritis and production of proinflammatory cytokines by human T cells and macrophages.
Urasaki Y; Nori M; Iwata S; Sasaki T; Hosono O; Kawasaki H; Tanaka H; Dang NH; Ikeda E; Morimoto C
J Rheumatol; 2005 Sep; 32(9):1765-74. PubMed ID: 16142877
[TBL] [Abstract][Full Text] [Related]
22. Adenoviral vector-mediated overexpression of IL-4 in the knee joint of mice with collagen-induced arthritis prevents cartilage destruction.
Lubberts E; Joosten LA; van Den Bersselaar L; Helsen MM; Bakker AC; van Meurs JB; Graham FL; Richards CD; van Den Berg WB
J Immunol; 1999 Oct; 163(8):4546-56. PubMed ID: 10510398
[TBL] [Abstract][Full Text] [Related]
23. Blockade of the interleukin-21/interleukin-21 receptor pathway ameliorates disease in animal models of rheumatoid arthritis.
Young DA; Hegen M; Ma HL; Whitters MJ; Albert LM; Lowe L; Senices M; Wu PW; Sibley B; Leathurby Y; Brown TP; Nickerson-Nutter C; Keith JC; Collins M
Arthritis Rheum; 2007 Apr; 56(4):1152-63. PubMed ID: 17393408
[TBL] [Abstract][Full Text] [Related]
24. Amelioration of accelerated collagen induced arthritis by a novel calcineurin inhibitor, ISA(TX)247.
Maksymowych WP; Jhangri GS; Aspeslet L; Abel MD; Trepanier DJ; Naicker S; Freitag DG; Cooper BL; Foster RT; Yatscoff RW
J Rheumatol; 2002 Aug; 29(8):1646-52. PubMed ID: 12180723
[TBL] [Abstract][Full Text] [Related]
25. Mechanisms of effects of complement inhibition in murine collagen-induced arthritis.
Banda NK; Kraus D; Vondracek A; Huynh LH; Bendele A; Holers VM; Arend WP
Arthritis Rheum; 2002 Nov; 46(11):3065-75. PubMed ID: 12428251
[TBL] [Abstract][Full Text] [Related]
26. Pathophysiological role of mast cells in collagen-induced arthritis: study with a cysteinyl leukotriene receptor antagonist, montelukast.
Shiota N; Shimoura K; Okunishi H
Eur J Pharmacol; 2006 Oct; 548(1-3):158-66. PubMed ID: 16949072
[TBL] [Abstract][Full Text] [Related]
27. A comparative study into the mechanisms of action of anti-tumor necrosis factor alpha, anti-CD4, and combined anti-tumor necrosis factor alpha/anti-CD4 treatment in early collagen-induced arthritis.
Marinova-Mutafchieva L; Williams RO; Mauri C; Mason LJ; Walmsley MJ; Taylor PC; Feldmann M; Maini RN
Arthritis Rheum; 2000 Mar; 43(3):638-44. PubMed ID: 10728758
[TBL] [Abstract][Full Text] [Related]
28. Sulfuretin, a major flavonoid isolated from Rhus verniciflua, ameliorates experimental arthritis in mice.
Lee YR; Hwang JK; Koh HW; Jang KY; Lee JH; Park JW; Park BH
Life Sci; 2012 May; 90(19-20):799-807. PubMed ID: 22521292
[TBL] [Abstract][Full Text] [Related]
29. Contribution of OX40/OX40 ligand interaction to the pathogenesis of rheumatoid arthritis.
Yoshioka T; Nakajima A; Akiba H; Ishiwata T; Asano G; Yoshino S; Yagita H; Okumura K
Eur J Immunol; 2000 Oct; 30(10):2815-23. PubMed ID: 11069062
[TBL] [Abstract][Full Text] [Related]
30. [Preliminary study of effects and mechanisms of qingpeng paste on type II collagen-induced arthritis in rats].
He CY; Li N; Ma J; Chen LH; Li WD
Zhongguo Zhong Yao Za Zhi; 2008 Jun; 33(12):1455-8. PubMed ID: 18837355
[TBL] [Abstract][Full Text] [Related]
31. THR0921, a novel peroxisome proliferator-activated receptor gamma agonist, reduces the severity of collagen-induced arthritis.
Tomita T; Kakiuchi Y; Tsao PS
Arthritis Res Ther; 2006; 8(1):R7. PubMed ID: 16356194
[TBL] [Abstract][Full Text] [Related]
32. Absence of endogeneous interleukin-10 enhances the evolution of murine type-II collagen-induced arthritis.
Cuzzocrea S; Mazzon E; Dugo L; Serraino I; Britti D; De Maio M; Caputi AP
Eur Cytokine Netw; 2001; 12(4):568-80. PubMed ID: 11781183
[TBL] [Abstract][Full Text] [Related]
33. Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice: a comparative study using anti-TNFalpha, anti-IL-1alpha/beta and IL-1Ra.
Joosten LA; Helsen MM; van de Loo FA; van den Berg WB
Arthritis Rheum; 2008 Feb; 58(2 Suppl):S110-22. PubMed ID: 18240201
[TBL] [Abstract][Full Text] [Related]
34. Madecassoside attenuates inflammatory response on collagen-induced arthritis in DBA/1 mice.
Li H; Gong X; Zhang L; Zhang Z; Luo F; Zhou Q; Chen J; Wan J
Phytomedicine; 2009 Jun; 16(6-7):538-46. PubMed ID: 19135346
[TBL] [Abstract][Full Text] [Related]
35. Antigen-specific immunomodulation of collagen-induced arthritis with tumor necrosis factor-stimulated dendritic cells.
van Duivenvoorde LM; Louis-Plence P; Apparailly F; van der Voort EI; Huizinga TW; Jorgensen C; Toes RE
Arthritis Rheum; 2004 Oct; 50(10):3354-64. PubMed ID: 15476255
[TBL] [Abstract][Full Text] [Related]
36. Severe inflammatory arthritis and lymphadenopathy in the absence of TNF.
Campbell IK; O'Donnell K; Lawlor KE; Wicks IP
J Clin Invest; 2001 Jun; 107(12):1519-27. PubMed ID: 11413159
[TBL] [Abstract][Full Text] [Related]
37. Amelioration of collagen-induced arthritis in DBA/1J mice by recombinant TSG-6, a tumor necrosis factor/interleukin-1-inducible protein.
Mindrescu C; Thorbecke GJ; Klein MJ; Vilcek J; Wisniewski HG
Arthritis Rheum; 2000 Dec; 43(12):2668-77. PubMed ID: 11145024
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic actions of cyclosporine and anti-tumor necrosis factor alpha in collagen-induced arthritis and the effect of combination therapy.
Williams RO; Mauri C; Mason LJ; Marinova-Mutafchieva L; Ross SE; Feldmann M; Maini RN
Arthritis Rheum; 1998 Oct; 41(10):1806-12. PubMed ID: 9778221
[TBL] [Abstract][Full Text] [Related]
39. Inflammatory cytokine levels in paw tissues during development of rat collagen-induced arthritis: effect of FK506, an inhibitor of T cell activation.
Magari K; Miyata S; Ohkubo Y; Mutoh S
Inflamm Res; 2004 Sep; 53(9):469-74. PubMed ID: 15551000
[TBL] [Abstract][Full Text] [Related]
40. Role of TL1A in the pathogenesis of rheumatoid arthritis.
Zhang J; Wang X; Fahmi H; Wojcik S; Fikes J; Yu Y; Wu J; Luo H
J Immunol; 2009 Oct; 183(8):5350-7. PubMed ID: 19786547
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
